-
2023 China (Beijing) International Electronic Scale Exhibition
Time of Update: 2022-10-25
2023 China (Beijing) International Electronic Scale Exhibition China (Beijing) International Electronic Weighing Instrument Exhibition2023 【Basic Information】 When: June 16-18, 2023 Venue: Beijing Et
-
Mindray, WuXi and Hengrui set off a "buyback wave"! Multi-dimensional "bottoming" boost
Time of Update: 2022-10-25
According to incomplete statistics from the New Media Center of "Medical Economic News", in the past month, WuXi Biologics has been active in repurchases, with a total of nearly 1 billion Hong Kong dollars invested in eight repurchase executions and more than 20 million shares repurchased (data as of the close of the market on October 14).
-
Invisible orthodontics will also be collected! Will the market landscape change?
Time of Update: 2022-10-25
js?cdnversion='+~(-new Date()/36e5)]; Due to the high price of dental implants, the news and progress of dental implant collection in the past two years have attracted the attention of consumers.
-
Exposure! Another batch of pharmaceutical companies were fined for producing and selling counterfeit drugs
Time of Update: 2022-10-25
According to the penalty documents, the parties purchased a total of 15kg of the above-mentioned madder from a company in Yunnan on September 2, 2021, January 24, April 27, and May 11, 2022, with a unit price of 316.
-
The end of 2022 is approaching, and pharmaceutical executives are leaving!
Time of Update: 2022-10-25
On October 10, Hengrui Pharmaceutical announced that the company's board of directors recently received a resignation report from Tao Weikang, deputy general manager of the company, and after resigning from the above position due to personal reasons, Tao Weikang will no longer hold any position in the company.
-
Pharmaceutical companies are laying out shingles vaccines, and how is the current research and development progress
Time of Update: 2022-10-25
On October 21, multinational pharmaceutical company GlaxoSmithKline (GSK) announced positive interim results in the expansion of its recombinant herpes zoster vaccine "Xin'anlishi".
On October 21, multinational pharmaceutical company GlaxoSmithKline (GSK) announced positive interim results in the expansion of its recombinant herpes zoster vaccine "Xin'anlishi".
-
Novartis, Abbott, Sanofi, Merck split generic drug apocalypse!
Time of Update: 2022-10-25
Looking at the entire generic drug industry, it has been infinitely prosperous: large companies continue to buy, mergers and acquisitions and expand, are sought after by capital and leverage, and have also ushered in a surge in stock price market value; Nowadays, many products and documents are changed or discontinued through subtraction, divestiture and sale.
-
Analysis and revision of GMP deficiency in China in 2010
Time of Update: 2022-10-25
There is no doubt that China's GMP (2010 Revision), which came into effect on March 1, 2011, has played a key role in standardizing the business practices of Chinese pharmaceutical companies, promoti
-
The market potential of proprietary Chinese medicine gastric medicine is huge, which has attracted many pharmaceutical companies to make efforts to grab food
Time of Update: 2022-10-25
Qingfeng Pharmaceutical is also actively deploying in the Chinese proprietary medicine gastric medicine market, and has won the production approval of monkey mushroom drink oral liquid, and Ollantic Gastro Kang tablets are expected to become the company's first Class 1 new drug in this field.
-
The first generic drug has become a place for pharmaceutical companies, and a large number of drugs will be the first imitation
Time of Update: 2022-10-25
In terms of generic drugs, in addition to Shuanghe Pharmaceutical, which reported production this time, Sichuan Guowei Pharmaceutical submitted a marketing application in November 2021, which is still under review and approval.
-
A number of CXO heads disclosed "eye-catching" report cards in the first three quarters, and the industry is prosperous
Time of Update: 2022-10-25
Zhaoyan New Drug issued a performance forecast announcement on the evening of October 18, and it is expected to achieve a net profit attributable to the parent in the first three quarters of about 607 million to 657 million yuan, a year-on-year increase of about 144.
-
Chinese pharmaceutical companies are frequently acquiring overseas companies to accelerate internationalization
Time of Update: 2022-10-25
Therefore, for pharmaceutical companies initiating mergers and acquisitions, choosing to acquire small pharmaceutical companies with R&D and production capabilities can quickly expand their product lines and cut into new fields.
-
How will the pharmaceutical equipment industry develop in the future? Four trends have long been known
Time of Update: 2022-10-25
com) According to the public data of listed pharmaceutical equipment, we can see that in the past two years, the performance of pharmaceutical machinery enterprises represented by Chutian Science and Technology, Dongfulong and other heads in China has achieved steady growth, and the overall prosperity of the industry is relatively high.
-
$610 million! Leading multinational pharmaceutical manufacturers launched large acquisitions
Time of Update: 2022-10-25
Currently, Akoouos is developing viral gene therapy for the treatment of inner ear disorders, including sensorineural hearing loss.
Currently, Akoouos is developing viral gene therapy for the treatment of inner ear disorders, including sensorineural hearing loss.
-
The performance of Kun Pharmaceutical Group has grown, and the upward pressure on raw materials has increased!
Time of Update: 2022-10-25
Baishu, Henan and other production areas began to produce new, it is expected that this year's new goods output is not large, the market source of small quantities continues to be good, merchants actively purchase and sell, the market has maintained stable operation in recent times, the price of Anhui biennial tablets is between 32-33 yuan, and the market is optimistic.
-
The large-scale planting of traditional Chinese medicinal materials helps enrich the people and increase income and promotes rural revitalization
Time of Update: 2022-10-25
Zhangxian is located in the south-central part of Gansu Province, located in the transition zone of the West Qinling Mountains and the Loess Plateau, with an average altitude of more than 1,800 meters, which is suitable for the cultivation of traditional Chinese medicinal materials.
-
Will the eighth batch of collective procurement include biosimilars? 180 companies compete for the 10 billion market!
Time of Update: 2022-10-25
With the end of the seventh batch of collective procurement, the eighth batch of collective procurement has become a hot topic in the industry. Among them, the widely concerned "biological drug colle
-
Will the eighth batch of collective procurement include biosimilars? One article combs 180 enterprises such as Qilu, Cinda, and Chia Tai Tianqing to compete for the 10 billion market!
Time of Update: 2022-10-25
Arrows on the strings "National procurement" is poised to surge in the market of 10 billion The National Health Insurance Bureau said in its reply letter that at present, 6 batches of chemical drugs and 1 batch of biological drugs (insulin special) have been purchased in a centralized manner, and positive progress has been made.
-
Has the "proportion of medicine" changed its taste? Hospital assessment urgently needs to be refined!
Time of Update: 2022-10-25
The reform of medical insurance payment methods from charging by service items to paying for budget management is in full swing across the country. The basic principle of the reform is to partially s
-
Local innovative pharmaceutical companies are on the rise, and another multinational pharmaceutical company executive has chosen to join
Time of Update: 2022-10-25
Recently, Sihe Gene released news announcing that Huang Yue, former head of translational medicine at Merck China, officially joined Sihe Genomics as the Chief Translational Science Officer (CTO), fully responsible for the preclinical and clinical research and development of Sihe Gene's independent innovation antisense oligonucleic acid drug research and development project.